Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
Yahoo Finance · Oct 16, 2025 · Chemomab Therapeutics Ltd DRC (CMMB)
VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and seizure management, respectively.
Not investment advice. Cached headline, not a full reprint.